Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Mar 2026 for Atara Biotherapeutics, Inc..
Filing timeline
BuySalePanacea Innovation Ltd
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+18.8%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -20.2%Entry US$11.76 · Close at T+365 US$9.38
- -37.6%Entry US$13.02 · Close at T+365 US$8.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Panacea Innovation Ltd: trading record in brief
Panacea Innovation Ltd is a declared insider of Atara Biotherapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 17 July 2025 to 17 March 2026, the count stands at 7 filings.
Both buying and selling appear: 2 purchases worth €736k, against 1 sale worth €421k. Purchases outweigh sales by €315k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 19 March 2026, the filings show a share grant worth €23 in Atara Biotherapeutics, Inc. The last insider purchase was made public on 19 August 2025, 431 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Panacea Innovation Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
259,163 shares0.0% of flowCommon StockSEC:0001193125-26-116060:0
80,554 shares@ US$6.070742.2% of flowCommon StockSEC:0001193125-26-013358:0
48,737 shares0.0% of flowCommon StockSEC:0001193125-25-304018:0
55,000 shares@ US$12.189557.8% of flowCommon StockSEC:0000950170-25-110310:0
Canonical exit: 13 Nov 2025 (T+90)
19,335 shares@ US$9.6391100.0% of flowCommon StockSEC:0000950170-25-097087:0
Canonical exit: 15 Oct 2025 (T+90)
5 of 5 declarations
